A new, non-phosphatase role for PRLs in cancer was recently proposed, whereby PRL binds to magnesium transporters of the cyclin M (CNNM) family to increase intracellular magnesium concentration by either increasing its influx or blocking its efflux. This evidence concerns the gene PRL and cancer.